This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped
{ "resourceType": "MedicationDispense", "id": "meddisp0317", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "meddisp0317" </p></div><p><b>status</b>: stopped</p><p><b>medication</b>: <a name=\"med0306\"> </a></p><blockquote><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "med0306" </p></div><p><b>code</b>: Adcetris (Brentuximab Vedotin 50mg/10.5ml) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ndc.html\">National drug codes</a>#51144-050-01)</span></p><p><b>manufacturer</b>: <a href=\"organization-mmanu.html\">Organization/mmanu</a> "Acme Corporation"</p><p><b>form</b>: Lyophilized powder for injectable solution (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#421637006)</span></p></blockquote><p><b>subject</b>: <a href=\"patient-pat1.html\">Patient/pat1: Donald Duck</a> "Duck DONALD"</p><h3>Performers</h3><table class=\"grid\"><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a href=\"practitioner-f006.html\">Practitioner/f006</a> "Rob VAN DEN BERK"</td></tr></table><p><b>authorizingPrescription</b>: <a href=\"medicationrequest-medrx0316.html\">MedicationRequest/medrx0316</a></p><p><b>type</b>: Trial Fill <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ActCode.html\">ActCode</a>#TF)</span></p><p><b>quantity</b>: 3(unit 415818005 from http://snomed.info/sct)<span style=\"background: LightGoldenRodYellow\"> (Details: SNOMED CT code 415818005 = '415818005')</span></p><p><b>daysSupply</b>: 1 Day<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code d = 'd')</span></p><p><b>whenPrepared</b>: 2015-06-25T07:13:00+05:00</p><p><b>whenHandedOver</b>: 2015-06-26T07:13:00+05:00</p></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0306", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "51144-050-01", "display": "Adcetris (Brentuximab Vedotin 50mg/10.5ml)" } ] }, "manufacturer": { "reference": "Organization/mmanu" }, "form": { "coding": [ { "system": "http://snomed.info/sct", "code": "421637006", "display": "Lyophilized powder for injectable solution (qualifier value)" } ] } } ], "status": "stopped", "medicationReference": { "reference": "#med0306", "display": "Brentixumab Vedotin (Adcetris)" }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck" }, "performer": [ { "actor": { "reference": "Practitioner/f006" } } ], "authorizingPrescription": [ { "reference": "MedicationRequest/medrx0316" } ], "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode", "code": "TF", "display": "Trial Fill" } ] }, "quantity": { "value": 3, "system": "http://snomed.info/sct", "code": "415818005" }, "daysSupply": { "value": 1, "unit": "Day", "system": "http://unitsofmeasure.org", "code": "d" }, "whenPrepared": "2015-06-25T07:13:00+05:00", "whenHandedOver": "2015-06-26T07:13:00+05:00", "dosageInstruction": [ { "sequence": 1, "text": "1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles", "timing": { "repeat": { "count": 16, "frequency": 1, "period": 3, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "255560000", "display": "Intravenous" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 1.8, "unit": "mg/kg", "system": "http://unitsofmeasure.org", "code": "mg/kg" } } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.